Average Co-Inventor Count = 5.81
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nerviano Medical Sciences S.r.l. (17 from 138 patents)
2. Farmitalia Carlo Erba (3 from 208 patents)
3. Pharmacia Corporation (2 from 220 patents)
4. Pharmacia & Upjohn (2 from 117 patents)
5. Pfizer Italia S.r.l. (2 from 23 patents)
6. Pierrel Spa (1 from 25 patents)
27 patents:
1. 10081622 - Substituted indazole derivatives active as kinase inhibitors
2. 9670191 - Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
3. 9616059 - Substituted indazole derivatives active as kinase inhibitors
4. 9255087 - Substituted indazole derivatives active as kinase inhibitors
5. 9102662 - Substituted indazole derivatives active as kinase inhibitors
6. 9085558 - Substituted indazole derivatives active as kinase inhibitors
7. 9056854 - Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
8. 9029356 - Substituted indazole derivatives active as kinase inhibitors
9. 8906934 - Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
10. 8673893 - Substituted indazole derivatives active as kinase inhibitors
11. 8658662 - Crystalline CDC7 inhibitor salts
12. 8399668 - Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides
13. 8299057 - Substituted indazole derivatives active as kinase inhibitors
14. 8293762 - Isoquinolinopyrrolopyridinones active as kinase inhibitors
15. 8263604 - Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors